Xponance’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,233
| Closed | -$334K | – | 1293 |
|
|
2023
Q1 | $334K | Sell |
8,233
-6,181
| -43% | -$251K | ﹤0.01% | 1018 |
|
|
2022
Q4 | $648K | Buy |
14,414
+814
| +6% | +$36.6K | 0.01% | 799 |
|
|
2022
Q3 | $651K | Buy |
13,600
+54
| +0.4% | +$2.59K | 0.01% | 732 |
|
|
2022
Q2 | $802K | Buy |
13,546
+616
| +5% | +$36.5K | 0.02% | 656 |
|
|
2022
Q1 | $1.5M | Sell |
12,930
-240
| -2% | -$27.9K | 0.03% | 457 |
|
|
2021
Q4 | $1.98M | Buy |
13,170
+400
| +3% | +$60.2K | 0.03% | 391 |
|
|
2021
Q3 | $1.52M | Buy |
12,770
+5,996
| +89% | +$716K | 0.03% | 424 |
|
|
2021
Q2 | $660K | Buy |
6,774
+1,106
| +20% | +$108K | 0.01% | 780 |
|
|
2021
Q1 | $500K | Buy |
5,668
+161
| +3% | +$14.2K | 0.01% | 782 |
|
|
2020
Q4 | $527K | Sell |
5,507
-3
| -0.1% | -$287 | 0.01% | 711 |
|
|
2020
Q3 | $625K | Buy |
5,510
+135
| +3% | +$15.3K | 0.02% | 560 |
|
|
2020
Q2 | $532K | Buy |
+5,375
| New | +$532K | 0.01% | 581 |
|